Clinical Trial

Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if Triptorelin test works to early diagnose hypogonadotrophic hypogonadism in adolescents. The main questions it aims to answer are: • Does gonadotropin and gonadal steroids responses to Triptorelin test be useful to diagnose early hypogonadotrophic hypogonadism? Researchers will compare gonadotrophins and gonadal steroids in response to Triptorelin subucutaneos test with clasiccal GnRH infusion to diagnose hypogonadotrophic hypogonadism. Participants will performed two test: * Triptorelin test (subcutanous) * LHRH infusion test
Trial Details
NCT Number NCT06691815
Lead Sponsor Hospital de Niños R. Gutierrez de Buenos Aires
Conditions Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)
Enrollment 48 participants
Start Date 2022-08-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2024-11-15